Fig. 4: SOT recipients have higher levels of specific serum chemokines and lower levels of IFN-gamma. | Nature Communications

Fig. 4: SOT recipients have higher levels of specific serum chemokines and lower levels of IFN-gamma.

From: Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients

Fig. 4

a Bar plots showing proteins that are differentially expressed between control (blue, n = 161) and transplant patients (yellow, n = 80) at Visit 1 (adjusted P < 0.05). b Box plots showing the levels of CX3CL1 and IFNG at Visit 1. a, b P values were calculated using a linear model and Benjamini–Hochberg correction. Boxes show the median and interquartile range (IQR), whiskers were calculated as the 25th percentile minus 1.5 times the IQR and the 75th percentile plus 1.5 times the IQR. c Scatter plot showing the dynamics of CXCL11 level after hospital admission (without adjusting for SARS-CoV-2 viral rpM). The ribbons indicate the 95% confidence interval of the linear mixed-effects model fits. P value was calculated using a linear mixed-effects model and Benjamini–Hochberg correction. The number of patients sampled at each time point is depicted graphically below the X axis of (c).

Back to article page